Journal: Oral diseases

Article Title: Glimpses of the near future: A new generation of mTOR inhibitors.

PMID/MRN: 27809391

Publication Date: 2016-Nov-03

Abstract:

The PI3K/AKT/mTOR intracellular signaling pathway is frequently activated in a wide variety of malignant neoplasms, controlling many cancer-related biological processes, such as cell growth and survival, protein translation, cytoskeletal organization and metabolism (Polivka and Janku, 2014; Moschetta etÊal, 2014). In Head and Neck Squamous Cell Carcinoma (HNSCC), aberrant activation of the mTOR pathway is regarded as one of the prevailing cell signaling abnormalities in both HPV- and HPV+ cancers, representing a point of convergence of various genetic and epigenetic alterations (Iglesias-Bartolome etÊal, 2013). A recent meta-analysis has indicated that abnormal expression of mTOR pathway-related proteins is identified in 74,42% of HNSCC and is significantly associated with poor survival (Marques etÊal, 2016). This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.